Study of the Nevisense Device to Assess Atypical Skin Lesions

Completed

Conditions studied: Nevus, Multiple Nevi, Large Acquired Nevi, Skin Lesion

In brief

The purpose of this study is to find out whether the Nevisense device can provide useful information about atypical moles to complement the usual assessments done during routine screening for melanoma. Assessing particpants' moles with the Nevisense device may help improve screening methods for the early detection of melanoma in people with atypical mole syndrome.

Key facts

Study ID
NCT04705168
Run by
Memorial Sloan Kettering Cancer Center
People needed
40
Starts
2021-01-08
Expected to finish
2025-11-18
Last updated by the study team
2025-11-20

Who can join

Age: 30 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.